LATEST NEWS 2017-04-19T19:25:29+00:00

LATEST NEWS

BUFFALO BIOLABS, LLC CONTRACTED BY INCURON LLC AS PREFERRED PRECLINICAL PARTNER.

Buffalo Biolabs, LLC (BBL) and Incuron LLC announced today that Incuron has retained the services of Buffalo Biolabs for preclinical murine studies. The studies, to be conducted in 2014, will advance and enhance the understanding of the efficacy and mechanism of work of Incuron’s flagship compound CBLO137. According to Vladimir [...]

April 1st, 2014|

BUFFALO BIOLABS, LLC STRENGTHENS ITS WORKFORCE WITH NEW LABORATORY AND PRECLINICAL SERVICES PERSONNEL.

Buffalo Biolabs, LLC (BBL) and Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced today that because of maturation of CBLI' development pipeline and a reduced need for certain services, it has transferred laboratory and preclinical services personnel to BBL, an entity affiliated with one of the CBLI's co-founders, Dr. Andrei Gudkov, PhD, [...]

October 1st, 2013|